From heart disease to neurodegeneration, Novartis makes bold deals in 2025 to expand its drug pipeline globally.

EINPresswire/ -- According to DataM Intelligence, the RNAi Therapeutics Market will grow from USD 2.60 billion in 2024 to USD 8.80 billion by 2033, expanding at a robust CAGR of 14.6% between 2025 and ...

Significant advancements in gene silencing and gene editing offer new hope for treating rare disorders. Techniques like RNA ...

Our RNAi play came from the understanding that personalization and the development of curated therapies are the future of medicine. Read more ...

In a study published in Nature Communications, a research team demonstrates the all-electrical control of quantum ...

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...

Corn rootworms, pests responsible for billions of dollars in yearly crop losses, are evolving resistance that weakens even the latest biotechnology controls, according to a new study published in the ...